Invention Grant
- Patent Title: Antibacterial activity of functionalized dihydropyrimidines
-
Application No.: US17574998Application Date: 2022-01-13
-
Publication No.: US12006297B2Publication Date: 2024-06-11
- Inventor: Matthew Charles O'Reilly
- Applicant: WiSys Technology Foundation, Inc.
- Applicant Address: US WI Madison
- Assignee: WiSys Technology Foundation, Inc.
- Current Assignee: WiSys Technology Foundation, Inc.
- Current Assignee Address: US WI Madison
- Agency: Boyle Fredrickson S.C.
- Main IPC: C07D239/22
- IPC: C07D239/22 ; A61P31/04 ; C07D403/04
Abstract:
Emmacin-related substituted dihydropyrimidine compounds demonstrate potency at low concentrations and inhibit Methicillin-resistant S. aureus growth. One such compound is:
Public/Granted literature
- US20220220082A1 Antibacterial Activity of Functionalized Dihydropyrimidines Public/Granted day:2022-07-14
Information query
